Delivery Order SPE2DR25D2101-SPE2DR26F47QF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $15,756.32 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 26, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $16,604.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of TUKYSA 150 mg, a pharmaceutical product supporting military healthcare needs. This non-competitive delivery order, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $47,268.96 for TUKYSA 150 mg tablets (120-count units) from the Defense Logistics Agency Medical Supply Chain. This competitive award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, carries firm fixed pricing and represents a non-set-aside delivery order. The contract is performed at the vendor's Conshohocken location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 tablets of TUKYSA 150 mg medication with a ceiling value of $13,381.41. The contract is a firm fixed price delivery order with an ultimate completion date of January 21, 2026, and was awarded on December 29, 2025 without a set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TUKYSA 150 MG TABLET UU 120S. The award, valued at $12,273.50, has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceuticals, medical supplies, and related distribution services...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $6,125.65 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TUKYSA 150 MG TABLET. The contract has a completion date of February 21, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp, as a prime contractor, has a long-standing relationship with DLA Troop Support Medical, providing a wide range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $20,035.80 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, with a completion date of February 10, 2026. The order is for TUKYSA 150 mg tablets in quantities of 60 units and represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order was...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order contract by the Defense Logistics Agency (DLA) worth $24,502.60 for the supply of TUKYSA 150 MG TABLET medication. The contract has a firm fixed price pricing type and a completion date of March 6, 2024. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency has awarded a delivery order valued at $15,899.20 to AmerisourceBergen Drug Corp for the supply of TUKYSA 150 mg tablets (60-count units). This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by November 25, 2025. The award was issued on November 3, 2025, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the provision of the drug product TUKYSA 150 MG TABLET, with a ceiling value of $18,376.95 and a completion date of July 15, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47QFDelivery Order
On January 22, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $13,381.41 to AmerisourceBergen Drug Corp for 120 units of TUKYSA 150 MG tablets. This firm fixed-price, non-set-aside delivery order is scheduled for completion by February 12, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical supplier to federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 1/21/26 |